Differential effects of sulindac on renal hemodynamics and function in the rat

被引:2
|
作者
Kramp, RA
Caron, N
Genard, J
Lejeune, C
Gulbis, E
Herman, A
机构
[1] UNIV INSTELLING ANTWERP,DIV PHARMACOL,B-2610 WILRIJK,BELGIUM
[2] CAMA,LB,B-1440 WAUTHIER BRAINE,BELGIUM
关键词
non-steroidal anti-inflammatory drug; kidney; circulation; prostanoid; plasma renin activity; cytochrome P-450 activity; Na+ excretion;
D O I
10.1016/S0014-2999(97)00178-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Renal hemodynamics were studied using an electromagnetic perivascular flow sensor in anesthetized rats injected i.v. with vehicle, 5 or 10 mg/kg body weight (b.w.) sulindac. No hemodynamic changes occurred with vehicle (n = 6), but mean arterial pressure was significantly decreased (by 15 mmHg) with sulindac (n = 12). In the 5 mg/kg b.w. sulindac group (n = 7), renal blood flow progressively and significantly increased from 7.88 +/- 0.36 to 8.98 +/- 0.58 ml/min, except during concomitant intrarenal infusion of 3 mg/kg b.w. per h proadifen (n = 7). The pressure limits for efficient and no renal blood flow autoregulation remained unchanged (approx. 100 and 80 mmHg, respectively). In the 10 mg/kg b.w, sulindac group (n = 5), renal blood flow did not change but autoregulatory pressure limits were lowered by 10 mmHg 2 h after treatment (P < 0.025). Also, Na+ retention was marked. Prostanoid excretion in urine was significantly reduced with either dose but basal plasma renin activity was not (about 8 ng/ml per h; n = 15). When plasma renin activity was enhanced after a reduction in renal perfusion pressure (n = 21), it was decreased from 11.5 +/- 1.2 to 7.4 +/- 0.2 ng/ml per h only by 10 mg/kg b.w. sulindac (P < 0.05; n = 6). In conclusion, differential effects of sulindac on renal hemodynamics, Nai excretion and plasma renin activity were demonstrated. Renal hemodynamic changes could be related in part to the cytochrome P-450 arachidonic acid pathway. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 50 条
  • [1] Differential effects of sulindac on renal hemodynamics and function in the rat.
    Kramp, R
    Genard, J
    Caron, N
    Lejeune, C
    Ladriere, L
    Gulbis, E
    Herman, A
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1996, 431 (03): : 12 - 12
  • [2] THE EFFECTS OF HYPOTHERMIA ON RENAL-FUNCTION AND HEMODYNAMICS IN THE RAT
    BROMAN, H
    KALLSKOG, O
    ACTA PHYSIOLOGICA SCANDINAVICA, 1995, 153 (02): : 179 - 184
  • [3] EFFECTS OF SULINDAC ON RENAL-FUNCTION IN PATIENTS WITH CIRRHOSIS
    BRATER, DC
    ANDERSON, SA
    BROWNCARTWRIGHT, D
    CLINICAL RESEARCH, 1986, 34 (02): : A637 - A637
  • [4] Comparative effects of nabumetone, sulindac, and ibuprofen on renal function
    Cook, ME
    Wallin, JD
    Thakur, VD
    Kadowitz, PJ
    McNamara, DB
    Garcia, MM
    Lipani, JA
    Poland, M
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (06) : 1137 - 1144
  • [5] CHRONIC EFFECTS OF ORAL SULINDAC ON RENAL HEMODYNAMICS AND HORMONES IN SUBJECTS WITH CHRONIC RENAL-DISEASE
    SWAINSON, CP
    GRIFFITHS, P
    WATSON, ML
    CLINICAL SCIENCE, 1986, 70 (03) : 243 - 247
  • [6] EFFECTS OF ENDOTOXIN ON RENAL FUNCTION AND HEMODYNAMICS
    GILLENWATER, JY
    FROHLICH, ED
    DOOLEY, ES
    WILLS, JA
    ANGELOFF, G
    HABER, R
    ROZECKI, F
    AMERICAN JOURNAL OF PHYSIOLOGY, 1963, 205 (02): : 293 - +
  • [7] Differential effects of U46619 on renal regional hemodynamics in the rat: Involvement of endothelin
    Hantz, H
    Adesuyi, A
    Adebayo, O
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 299 (01): : 372 - 376
  • [8] EFFECTS OF AGE AND RENAL-FUNCTION ON SULINDAC DISPOSITION IN HUMANS
    HALL, SD
    HAMMAN, MA
    MURRAY, MD
    BRATER, DC
    FASEB JOURNAL, 1993, 7 (03): : A482 - A482
  • [9] THE EFFECT OF ANESTHESIA ON HEMODYNAMICS AND RENAL-FUNCTION IN THE RAT
    LINAS, SL
    BERL, T
    AISENBREY, GA
    BETTER, OS
    ANDERSON, RJ
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1980, 384 (02): : 135 - 141
  • [10] EFFECTS OF METHYLDOPA ON RENAL HEMODYNAMICS AND TUBULAR FUNCTION
    GRABIE, M
    NUSSBAUM, P
    GOLDFARB, S
    WALKER, BR
    GOLDBERG, M
    AGUS, ZS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 522 - 527